Scott R. Ward joins Creganna-Tactx Medical Board

– A former Medtronic Officer, new Director brings 30 years of industry experience –

Galway, Ireland, July 12th 2011 – Creganna-Tactx Medical, a leading provider of medical device outsourcing solutions, is pleased to announce that Mr. Scott R. Ward has been appointed to its Board of Directors. Mr. Ward has over 30 years experience in the medical devices industry and held a number of senior leadership positions with Medtronic including Senior Vice President & President, Medtronic CardioVascular. Mr. Ward will join the Creganna-Tactx Medical Board as a non-executive director, effective immediately.

Ian Quinn, Chairman, Creganna-Tactx Medical (left) pictured with Scott R. Ward (right) on his appointment to the Creganna-Tactx Medical Board of Directors.

As Vice President & President of Medtronic CardioVascular, Mr. Ward was responsible for the worldwide operations of the Coronary, Peripheral, Endovascular and Structural Heart Disease business units. Mr. Ward also held leadership positions in a number of businesses while at Medtronic including the Vascular, Neurological & Diabetes and Drug Delivery divisions. In addition to his appointment to the Board of Creganna-Tactx Medical, Mr. Ward also serves on the Board of  SurModics, Inc. (Nasdaq: SRDX) and is Chairman to the Board of MAP Pharmaceuticals Inc. (Nasdaq: MAPP) and Gillette Children’s Specialty Healthcare. Mr. Ward holds a B.S. in Genetics and Cell Biology and an M.S. in Toxicology from the University of Minnesota.

“Creganna-Tactx Medical is a dynamic company with an excellent reputation in the medical technology sector” said Ward on his appointment announcement. “I believe this success is based on the company’s intense commitment to customer focused quality and their ability to address customer’s needs in a rapidly evolving healthcare market. By responding accordingly, the company is well positioned for the opportunities and challenges of the future.”

Commenting on the Board appointment, Chairman and Creganna-Tactx Medical founder Ian Quinn said “Scott Ward will be a substantial presence on our Board, his unparalleled experience and industry insight is invaluable at this time of significant growth and expansion for the company.”

Mr. Ward will be joining non-executive directors Bernard Collins, Sally Flanagan & Fabio Andreottola on the Board. In 2010 the company announced that Permira funds had acquired a majority shareholding in the company.

About Creganna-Tactx Medical
Creganna-Tactx Medical is ranked among the Top 10 global companies in the medical device outsourcing industry. The company specializes in the design and manufacture of minimally & less invasive delivery and access devices for a range of therapies. Serving over 400 companies across 30 countries, Creganna-Tactx Medical’s customers include the world’s leading medical device and lifescience companies. Headquartered in Galway, Ireland Creganna-Tactx Medical has a global operational footprint with design and manufacturing facilities spanning the US, Europe and Asia.

Press Enquiries:
Maura Leahy, Creganna-Tactx Medical
Tel: +353 91 757801

Website Design Ireland by Irish Web Designers Martec